Results 31 to 40 of about 919 (164)

Identification of the Potential Molecular Mechanism of TGFBI Gene in Persistent Atrial Fibrillation

Computational and Mathematical Methods in Medicine, Volume 2022, Issue 1, 2022., 2022
Background. Transforming growth factor beta‐induced protein (TGFBI, encoded by TGFBI gene), is an extracellular matrix protein, widely expressed in variety of tissues. It binds to collagens type I, II, and IV and plays important roles in the interactions of cell with cell, collagen, and matrix.
Yao-Zong Guan, Hao Liu, Huan-Jie Huang, Dong-Yan Liang, Si-Ying Wu, Tang Zhang, Huiling Chen   +6 more
wiley   +1 more source

Lowered intraocular pressure in a glaucoma patient after intravitreal injection of ocriplasmin

Clinical Ophthalmology, 2015
Michael McClintock,1 Mathew W MacCumber1,2 1Department of Ophthalmology, Rush University Medical Center, 2Illinois Retina Associates, S.C., Chicago, IL, USA Abstract: We report the case of a glaucoma patient who received a single intravitreal ...
McClintock M, MacCumber MW
doaj   +1 more source

Epiretinal membrane: A review

Clinical &Experimental Ophthalmology, Volume 49, Issue 3, Page 289-308, April 2021., 2021
Abstract The prevalence of epiretinal membrane (ERM) is 7% to 11.8%, with increasing age being the most important risk factor. Although most ERM is idiopathic, common secondary causes include cataract surgery, retinal vascular disease, uveitis and retinal tears.
Adrian T. Fung, Justin Galvin, Tuan Tran
wiley   +1 more source

Risk of Posterior Capsular Rupture during Phacoemulsification in Patients with the History of Anti‐VEGF Intravitreal Injections: Results from the Pan‐American Collaborative Retina Study (PACORES) Group

Journal of Ophthalmology, Volume 2021, Issue 1, 2021., 2021
Purpose. To assess the risk for capsular rupture during routine phacoemulsification in patients with a history of anti‐VEGF injections and other possible risk modifiers such as treatment patterns, type of anti‐VEGF agent, and experience of the surgeon, among others. Methods.
Raul Velez-Montoya, Idaira Sanchez-Santos, Mauricio Galvan-Chavez, Lihteh Wu, J. Fernando Arevalo, María H. Berrocal, Arturo A. Alezzandrini, Marta S. Figueroa, Roberto Gallego-Pinazo, Rosa Dolz-Marco, Clara Martinez-Rubio, Roberto Gonzalez-Salinas, Marco Pellegrini   +12 more
wiley   +1 more source

Italian real-life experience on the use of ocriplasmin [PDF]

, 2018
Objective To evaluate the success of an intravitreal injection of ocriplasmin to release symptomatic vitreomacular traction (VMT) and close a full-thickness macular hole.
Orsini E, Scialdone A, Recchimurzo N, Staurenghi G, Caporossi A, Cereda M, Virgili G, Carpineto P, Barca F, Meriotti C, Romano M, Gian MT, Morselli S, Tartaro R, Minnella A, Toso A, Romani A, De Cilla S, Fanton G, Brue C, Ramovecchi V, Moretti A, Iaculli C, Mastropasqua L, Radice P, Peruzzi S, Biraghi L, Arpa P, Mucciolo DP, Traversi C, Pieri B, Lovisolo C, Niro A, Mura M, Cappello E, Rizzo S, Iannetta D, Caporossi T, Caporossi T., Mucciolo, Dario Pasquale, Rizzo S., Virgili, Gianni, Rizzo, Stanislao, Barca, Francesco, Caporossi, Tomaso, Barca F., Tartaro, Ruggero, Virgili G., Lovisolo Carlo, Tartaro Ruggero, Rizzo Stanislao, Minnella Angelo, Iannetta Danilo, Iaculli Cristiana, Caporossi Tomaso, Romani Andrea, Mariotti Cesare, Scialdone Antonio, Mura Marco, Toso Antonio, Romano Mario, De Cillà Stefano, Orsini Emanuele, Carpineto Paolo, Virgili Gianni, Moretti Andrea, Cereda Matteo, Niro Alfredo, Barca Francesco, Cappello Ezio, Morselli Simonetta, Ramovecchi Vincenzo, Bruè Claudia, Caporossi Aldo, Fanton Giordano, Italian Ocriplasmin Group, Peruzzi Sabrina, Traversi Claudio, Mastropasqua Leonardo, Biraghi Luca, Staurenghi Giovanni, Tosi Gian Marco, Mucciolo Dario Pasquale, Arpa Paolo, Recchimurzo Nicola   +84 more
core   +2 more sources

Internal limiting membrane peeling in macular hole surgery

GMS German Medical Science, 2022
Since the era when macular hole was considered untreatable, macular hole surgery has come a long way to being one of the most successful surgeries. Internal limiting membrane (ILM) peeling has been an essential step of macular hole surgery since the ...
Pradhan, Deepti, Agarwal, Lalit, Joshi, Ichhya, Kushwaha, Anamika, Aditya, Kshitij, Kumari, Archana   +5 more
doaj   +1 more source

Spontaneous closure of small full‐thickness macular holes: Presumed role of Müller cells

Acta Ophthalmologica, Volume 98, Issue 4, Page e447-e456, June 2020., 2020
Abstract Purpose To document with spectral domain optical coherence tomography the formation and spontaneous closure of small full‐thickness macular holes and to propose the active role of Müller cells in macular hole closure. Methods A retrospective case series of five patients with spontaneous closure of macular holes is reviewed.
Andreas Bringmann, Tobias Duncker, Claudia Jochmann, Thomas Barth, Gernot I. W. Duncker, Peter Wiedemann   +5 more
wiley   +1 more source

Visual functional changes after ocriplasmin injection for vitreomacular traction: A microperimetric analysis

Taiwan Journal of Ophthalmology, 2021
PURPOSE: The purpose is to evaluate functional changes after ocriplasmin injection to treat vitreomacular traction (VMT) by microperimetry. MATERIALS AND METHODS: Prospective interventional study on patients underwent an intravitreal ocriplasmin ...
Claudio Furino, Alfredo Niro, Luigi Sborgia, Michele Reibaldi, Francesco Boscia, Giovanni Alessio   +5 more
doaj   +1 more source

Numerical Simulation of Thrombolysis in Robot‐Assisted Retinal Vein Cannulation

Complexity, Volume 2020, Issue 1, 2020., 2020
Robot‐assisted retinal cannulation is an eye surgical procedure which can dissolve the obstruction by using robot to inject anticoagulant into occluded vessel. The current research on the critical parameters of cannulation for human is scarce because of the immature technology.
Shunlei Li, Jiawen Pan, Juan Ji, Guanghang Wang, Baobao Qi, M. Irfan Uddin   +5 more
wiley   +1 more source

Anatomiska och funktionella resultat efter behandling av vitreomakulär traktion/adhesion (VMA/VMT) med vitrektomi eller ocriplasmin (Jetrea®)

, 2021
Background: Vitrectomy is a well-accomplished method for treatment of vitreomacular traction. In 2013, a new approach for treating symptomatic vitreomacular traction was presented, ocriplasmin (Jetrea®), that could perform enzymatic vitreolysis.
Dukay, Maria
core   +2 more sources